ID: ALA99229

Max Phase: Preclinical

Molecular Formula: C14H13NO4S

Molecular Weight: 291.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)ON(c1ccccc1)S(=O)(=O)c1ccccc1

Standard InChI:  InChI=1S/C14H13NO4S/c1-12(16)19-15(13-8-4-2-5-9-13)20(17,18)14-10-6-3-7-11-14/h2-11H,1H3

Standard InChI Key:  ZSODTYACKGCZAG-UHFFFAOYSA-N

Associated Targets(non-human)

Aldehyde dehydrogenase 1A1 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 291.33Molecular Weight (Monoisotopic): 291.0565AlogP: 2.36#Rotatable Bonds: 4
Polar Surface Area: 63.68Molecular Species: HBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.60CX LogD: 2.60
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.81Np Likeness Score: -0.71

References

1. Conway TT, DeMaster EG, Lee MJ, Nagasawa HT..  (1998)  Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.,  41  (15): [PMID:9667978] [10.1021/jm980200+]

Source